{"date":"2026-06-26","count":68,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2026-06-26-1946-1q6wz7h","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"19:46:46","subject":"公告本公司人事異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-26 19:46，「公告本公司人事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-26-1946-uo9i76","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"19:46:13","subject":"公告董事會決議通過增資新加坡子公司Lotus International Pte. Ltd.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-26 19:46，「公告董事會決議通過增資新加坡子公司Lotus International Pte. Ltd.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-26-1945-6or519","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"19:45:55","subject":"公告本公司董事會通過取消資金貸與子公司Lotus International Pte. Ltd.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-26 19:45，「公告本公司董事會通過取消資金貸與子公司Lotus International Pte. Ltd.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-26-1945-1gokjf3","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"19:45:40","subject":"公告董事會決議通過增資韓國子公司Alvogen Korea Holdings Ltd.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-26 19:45，「公告董事會決議通過增資韓國子公司Alvogen Korea Holdings Ltd.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-26-1944-s7hp0q","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"19:44:33","subject":"公告本公司董事會通過取消資金貸與子公司Alvogen Korea Holdings Ltd.額度","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-26 19:44，「公告本公司董事會通過取消資金貸與子公司Alvogen Korea Holdings Ltd.額度」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-26-1944-5pynro","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"19:44:16","subject":"代子公司公告資金貸與他人超限改善計畫執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-26 19:44，「代子公司公告資金貸與他人超限改善計畫執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-06-26-1941-1la1icy","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"19:41:34","subject":"公告本公司董事會決議實施第15次庫藏股買回","clause":"第35款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-06-26 19:41，「公告本公司董事會決議實施第15次庫藏股買回」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-06-26-1926-sm1dsw","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"19:26:26","subject":"本公司董事會簽署獨家營銷推廣合作協議","clause":"第10款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-06-26 19:26，「本公司董事會簽署獨家營銷推廣合作協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-26-1920-1x2b1f9","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"19:20:03","subject":"公告聯合骨科器材股份有限公司國內第五次無擔保轉換公司債(例：第一次有擔保)轉(交)換公司債(簡稱：聯合五，代碼：41295)停止受理轉交換等相關事項。","clause":"第53款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-26 19:20，「公告聯合骨科器材股份有限公司國內第五次無擔保轉換公司債(例：第一次有擔保)轉(交)換公司債(簡稱：聯合五，代碼：4129」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-26-1910-yhhzrn","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"19:10:47","subject":"(補充公司債停過日)公告本公司普通股現金股利除息基準日","clause":"第14款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-26 19:10，「(補充公司債停過日)公告本公司普通股現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1857-ps7z81","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"18:57:41","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 18:57，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1856-qrsqda","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"18:56:04","subject":"公告本公司獨立董事辭任","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 18:56，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1850-67rslk","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"18:50:29","subject":"公告本公司薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 18:50，「公告本公司薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1819-9hj3fk","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"18:19:04","subject":"公告本公司115年股東常會決議解除新任董事競業禁止之限制","clause":"第22款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 18:19，「公告本公司115年股東常會決議解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-26-1818-d8zwlw","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"18:18:08","subject":"公告本公司厄它培南原料藥新增產線取得台灣衛生福利部審查通過，認定符合藥物優良製造準則之西藥藥品優良製造規範（GMP）","clause":"第53款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-26 18:18，「公告本公司厄它培南原料藥新增產線取得台灣衛生福利部審查通過，認定符合藥物優良製造準則之西藥藥品優良製造規範（GMP）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1812-1fh57gu","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"18:12:29","subject":"公告本公司審計委員會之委員任期屆滿改選","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 18:12，「公告本公司審計委員會之委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1809-9769qc","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"18:09:59","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 18:09，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1807-1rayw5g","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"18:07:21","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 18:07，「公告本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-06-26-1757-15e1v8f","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"17:57:38","subject":"本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-06-26 17:57，「本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-06-26-1737-qf2jy8","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"17:37:35","subject":"公告本公司115年股東常會通過解除董事競業禁止限制案","clause":"第21款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-06-26 17:37，「公告本公司115年股東常會通過解除董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-06-26-1736-1jb8ii5","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"17:36:42","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-06-26 17:36，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-06-26-1724-tudzk1","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"17:24:42","subject":"公告本公司董事會決議辦理限制員工權利新股收買註銷減資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-06-26 17:24，「公告本公司董事會決議辦理限制員工權利新股收買註銷減資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-06-26-1724-7jq695","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"17:24:02","subject":"本公司接獲CRO機構通知，本公司研發中新藥ENERGI-F705PD巴金森氏症口服藥，向美國食品藥物管理局(FDA)申請執行人體二期臨床試驗(IND)","clause":"第10款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-06-26 17:24，「本公司接獲CRO機構通知，本公司研發中新藥ENERGI-F705PD巴金森氏症口服藥，向美國食品藥物管理局(FDA)申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-06-26-1721-l5e1ml","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"17:21:04","subject":"公告本公司董事會決議114年度限制員工權利新股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-06-26 17:21，「公告本公司董事會決議114年度限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-06-26-1717-1lvzn4z","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"17:17:47","subject":"公告本公司董事會決議修訂「115年度員工認股權憑證發行及認股辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-06-26 17:17，「公告本公司董事會決議修訂「115年度員工認股權憑證發行及認股辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-06-26-1716-1el2evl","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"17:16:40","subject":"公告本公司董事會決議修訂114年度限制員工權利新股發行辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-06-26 17:16，「公告本公司董事會決議修訂114年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-26-1715-eik570","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"17:15:08","subject":"公告本公司第五屆薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-26 17:15，「公告本公司第五屆薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-06-26-1714-opxsrv","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"17:14:42","subject":"公告本公司董事長訂定現金股利暨資本公積發放之除息基準日相關事宜","clause":"第31款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-06-26 17:14，「公告本公司董事長訂定現金股利暨資本公積發放之除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-26-1714-8ysypv","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"17:14:39","subject":"公告本公司第三屆審計委員會委員名單","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-26 17:14，「公告本公司第三屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-26-1714-1sdhj4y","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"17:14:17","subject":"公告本公司115年股東常會決議解除新任董事及其代表人競業禁止限制案","clause":"第21款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-26 17:14，「公告本公司115年股東常會決議解除新任董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-26-1712-14qg7aq","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"17:12:58","subject":"公告本公司115年改選董事選舉結果","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-26 17:12，「公告本公司115年改選董事選舉結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-26-1712-1jb8ii5","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"17:12:22","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-26 17:12，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-06-26-1712-1lhjqke","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"17:12:15","subject":"因應本公司申請股票上櫃委託簽證會計師出具內控專審報告","clause":"第25款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-06-26 17:12，「因應本公司申請股票上櫃委託簽證會計師出具內控專審報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-06-26-1705-vu23x7","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"17:05:08","subject":"公告本公司法人董事三顧股份有限公司改派代表人","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-06-26 17:05，「公告本公司法人董事三顧股份有限公司改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-06-26-1659-1aoweer","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:59:38","subject":"公告本公司董事會通過公司治理主管任命案","clause":"第11款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-06-26 16:59，「公告本公司董事會通過公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-06-26-1659-1jb8ii5","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:59:01","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-06-26 16:59，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-06-26-1658-iywrok","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:58:26","subject":"公告本公司115年股東常會補選董事一席","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-06-26 16:58，「公告本公司115年股東常會補選董事一席」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-06-26-1657-1a8scvn","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:57:51","subject":"公告本公司115年股東常會決議解除新任董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-06-26 16:57，「公告本公司115年股東常會決議解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-06-26-1653-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:53:21","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-06-26 16:53，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-06-26-1640-17bcntw","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"16:40:45","subject":"公告本公司受邀參加臺灣證券交易所舉辦之「東南亞創新資本平台」赴新加坡交流活動","clause":"第12款","fact_date":"2026-06-30","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-06-26 16:40，「公告本公司受邀參加臺灣證券交易所舉辦之「東南亞創新資本平台」赴新加坡交流活動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-06-26-1637-1pkubox","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:37:20","subject":"公告本公司115年股東常會通過解除本公司董事(含獨立董事)及其代表人競業禁止之限制","clause":"第22款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-06-26 16:37，「公告本公司115年股東常會通過解除本公司董事(含獨立董事)及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-06-26-1636-7gv6zx","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:36:35","subject":"公告本公司115年股東常會獨立董事增選當選名單","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-06-26 16:36，「公告本公司115年股東常會獨立董事增選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-06-26-1634-1jb8ii5","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:34:46","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-06-26 16:34，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-06-26-1633-p67uuk","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:33:48","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-06-26 16:33，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-06-26-1625-1f6cmaj","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"16:25:53","subject":"代重要子公司富康活力醫藥(股)公司公告董事會決議現金增資發行新股","clause":"第11款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-06-26 16:25，「代重要子公司富康活力醫藥(股)公司公告董事會決議現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-06-26-1624-16okbod","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"16:24:52","subject":"代重要子公司富康活力醫藥(股)公司公告股東會決議分配股利","clause":"第14款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-06-26 16:24，「代重要子公司富康活力醫藥(股)公司公告股東會決議分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-06-26-1604-100esni","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"16:04:06","subject":"公告本公司研發主管異動","clause":"第11款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-06-26 16:04，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-06-26-1556-w5j4lj","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"15:56:58","subject":"公告本公司115年股東常會決議通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-06-26 15:56，「公告本公司115年股東常會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-06-26-1554-1j9j8os","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"15:54:38","subject":"本公司一一五年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-06-26 15:54，「本公司一一五年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-06-26-1521-1jb8ii5","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"15:21:38","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-06-26 15:21，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-06-26-1519-861s21","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"15:19:12","subject":"本公司以股份轉換方式處分所持健亞生物科技(股)公司全部股份，並取得易威生醫科技(股)公司新發行普通股","clause":"第20款","fact_date":"2026-05-05","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-06-26 15:19，「本公司以股份轉換方式處分所持健亞生物科技(股)公司全部股份，並取得易威生醫科技(股)公司新發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-06-26-1512-19wk8sa","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"15:12:27","subject":"本公司因近期股價價格異常，應櫃買中心要求公布相關資訊，俾便投資人暸解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-06-26 15:12，「本公司因近期股價價格異常，應櫃買中心要求公布相關資訊，俾便投資人暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-06-26-1503-67rslk","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"15:03:13","subject":"公告本公司薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-06-26 15:03，「公告本公司薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-06-26-1453-ihvojw","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"14:53:09","subject":"公告第三屆「審計委員會」","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-06-26 14:53，「公告第三屆「審計委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-06-26-1451-umuizu","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"14:51:44","subject":"本公司召開法人說明會","clause":"第12款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-06-26 14:51，「本公司召開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-06-26-1443-11n5eud","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"14:43:34","subject":"本公司受邀參加群益金鼎證券與IR Trust共同舉辦之「再生醫療與消費醫療產業論壇」","clause":"第30款","fact_date":"2026-07-01","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-06-26 14:43，「本公司受邀參加群益金鼎證券與IR Trust共同舉辦之「再生醫療與消費醫療產業論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-06-26-1431-7rktoc","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"14:31:32","subject":"本公司115年股東常會決議解除董事競業禁止限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-06-26 14:31，「本公司115年股東常會決議解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-06-26-1430-1jb8ii5","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"14:30:46","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-06-26 14:30，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-06-26-1429-qcx1gh","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"14:29:41","subject":"公告本公司決議除息基準日","clause":"第14款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-06-26 14:29，「公告本公司決議除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-06-26-1427-9769qc","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"14:27:09","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-06-26 14:27，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-06-26-1424-xev7kf","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"14:24:45","subject":"公告本公司取得會計師114年內部控制專案審查報告","clause":"第29款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-06-26 14:24，「公告本公司取得會計師114年內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-06-26-1420-jq9l4i","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"14:20:03","subject":"公告本公司中華民國境內第四次有擔保轉換公司債收足債款","clause":"第51款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-06-26 14:20，「公告本公司中華民國境內第四次有擔保轉換公司債收足債款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-06-26-1416-6x316w","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"14:16:37","subject":"公告本公司股東會決議解除新任董事(含獨立董事)競業禁止之限制","clause":"第21款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-06-26 14:16，「公告本公司股東會決議解除新任董事(含獨立董事)競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-06-26-1414-1gb0xco","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"14:14:35","subject":"代子公司欣大首美達(股)公司公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-06-26 14:14，「代子公司欣大首美達(股)公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-06-26-1405-1wxzb4f","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-06-26","time":"14:05:53","subject":"公告本公司董事長依董事會授權訂定員工認股權憑證轉換普通股增資基準日","clause":"第53款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-06-26 14:05，「公告本公司董事長依董事會授權訂定員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-06-26-1403-7sf6el","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"14:03:30","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)","clause":"第6款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-06-26 14:03，「公告本公司115年股東常會全面改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-06-26-1342-1jb8ii5","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-06-26","time":"13:42:23","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-06-26 13:42，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-06-26-1126-1fq2tp3","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-06-26","time":"11:26:16","subject":"本公司受邀參加群益金鼎證券舉辦之再生醫療與消費醫療產業論壇","clause":"第30款","fact_date":"2026-07-01","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-06-26 11:26，「本公司受邀參加群益金鼎證券舉辦之再生醫療與消費醫療產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}